7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Werewolf Therapeutics Inc
(NASDAQ:HOWL) 

HOWL stock logo

Werewolf Therapeutics is a highly innovative company striving to redefine the cancer treatment landscape with potential best-in-class therapies.

Founded: 2017
CEO: Dan Hicklin  
Sector:
Industry:

Share this website to your friends
Werewolf Therapeutics Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 028.5657.1285.69114.25142.81171.37199.93
Werewolf Therapeutics Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 027.9155.8183.72111.63139.53167.44195.35
Werewolf Therapeutics Days Inventory Outstanding ttm (DIO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1,293.4-1,108.63-923.86-739.08-554.31-369.54-184.770
Werewolf Therapeutics Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.43-1.23-1.02-0.82-0.61-0.41-0.20
Werewolf Therapeutics Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.5-1.29-1.07-0.86-0.64-0.43-0.210
Werewolf Therapeutics Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.761.512.273.033.784.545.3
Werewolf Therapeutics P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 06.5713.1319.726.2732.8439.445.97
Werewolf Therapeutics (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -7.05-6.05-5.04-4.03-3.02-2.02-1.010
Werewolf Therapeutics P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.320.630.951.271.591.92.22
No extra charts and metrics for this ticker.